Author : CCT IMPACT Agent

Spectrum Therapeutics provides update on its global clinical research program and unveils pharmacovigilance program

CCT IMPACT Agent
Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines through clinical trials. Demand for cannabinoid-based medicines is emerging around the world. With a highly experienced...

Noramco Presents Comments And Answers Questions At FDA Hearing On Cannabidiol

CCT IMPACT Agent
Noramco, a leading manufacturer of cannabidiol (CBD) and related compounds presented testimony and answered questions at the Food and Drug Administration’s (FDA) Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds, Part 15 Public Hearing, that took place on Friday, May 31, 2019 in Silver Spring, Maryland. Speaking on behalf of Noramco, Bill Grubb, Chief Innovation...

Medicine Man Technologies, Inc. Announces Entry into Binding Term Sheets for Two Strategic Cannabis Acquisitions

CCT IMPACT Agent
Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or “Company”), a rapidly growing, vertically integrated cannabis operator, today is pleased to announce that it has entered into binding term sheets to acquire the assets and rights from Colorado-based Los Sueños Farms, LLC, North America’s largest sustainable cannabis farm. The Company has also entered into...

Fohse Secures Cannabis Grow Light Contract with Ontario-Based Curative Cannabis

CCT IMPACT Agent
FOHSE INC. (“Fohse” or the “Company”) is pleased to announce that it has finalized negotiations with 2368523 Ontario Limited (d/b/a) Curative Cannabis (“Curative Cannabis”) for a contract in which Fohse will become the exclusive partner for supplying cannabis grow lights to Curative Cannabis’ 30,000 square foot growing facility in Chatham-Kent, Ontario. Curative Cannabis...

Cannabistry Labs® Partners with M Plant Productions™ as Exclusive California Licensee

CCT IMPACT Agent
Cannabistry Labs, a pioneer in developing and licensing innovative products and revolutionary brands for the multi-billion-dollar legalized cannabis industry, today announces an exclusive California partnership with M Plant Productions, a premier manufacturer and marketer of cannabis infused products, for the company’s The Root of It All™ product line. Securing M Plant Productions as...

Prima launches signature wellness CBD products that harness therapeutic functional botanicals

CCT IMPACT Agent
Prima, the new industry-defining hemp CBD wellness brand, announced today the launch of three signature products in their body, beauty and supplement categories available at their new online shop at prima.co. Based in Santa Monica, CA, Prima’s founders are The Honest Company® Co-Founder, bestselling author and purpose-driven entrepreneur Christopher Gavigan, award-winning health...

HempFusion Announces Engagement of RADD Capital and Progress in $30+ Million Strategic Private Financing Initiative

CCT IMPACT Agent
HempFusion (“the Company”), a leading US hemp-based CBD company, with distribution to over 3,400 retailers and an expanding product catalog, is pleased to announce the engagement of RADD Capital (“RADD”) for advisory services related to its 2019 private US$30,000,000+ funding initiative. HempFusion launched the current initiative as part of its plan to diversify...

Consumer Product Leader Miramar Brands and Cannabis Brand Heavy Grass Ink Exclusive Licensing Partnership

CCT IMPACT Agent
Miramar Brands Group, Inc. and alternative cannabis brand Heavy Grass have signed a licensing deal that will extend the brand into numerous retail categories that embody the “Heavy Grass cannabis lifestyle.” Miramar will represent Heavy Grass in licensing opportunities for everything from apparel to home goods to cosmetics. The brand partnership...